Lantern Pharma Inc.
NASDAQLTRN short interest surges 46% in one week to 18.16% of float, driven by biotech volatility and high short-seller utilization at 84%.
Snapshot as of 8 May 2026
No long-form analysis yet for LTRN. Pulse alerts and the live data picture are available on ORTEX.
Open LTRN on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LTRN — free to start on ORTEX.
Sign up for free →Open LTRN on ORTEX